載入中
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
前收盤價
US$0.521
+US$0.041 · +8.54%
盤中時間採用ET。市場資料可能有所延遲。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日內區間
目前US$0.521
52週區間
目前US$0.521
盤中時間採用ET。市場資料可能有所延遲。
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
日內區間
目前US$0.521
52週區間
目前US$0.521
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 897.9萬 USD | 700.9萬 USD | 620.5萬 USD | 517.1萬 USD | 449.5萬 USD |
| 銷貨成本 | 633萬 USD | 550.3萬 USD | 439.8萬 USD | 405.4萬 USD | 374.1萬 USD |
| 毛利 | 264.9萬 USD | 150.6萬 USD | 180.7萬 USD | 111.7萬 USD | 75.4萬 USD |
| 研究與開發 | 1500.3萬 USD | 1363.4萬 USD | 798.1萬 USD | 781萬 USD | 515.8萬 USD |
| 銷售、一般及管理費用 | 3726萬 USD | 2137.5萬 USD | 1496.9萬 USD | 1202萬 USD | 1031.2萬 USD |
| 營業費用 | 5176.1萬 USD | 3500.9萬 USD | 2295萬 USD | 1983萬 USD | 1547萬 USD |
| 利息收入 | — | 155.7萬 USD | 129.2萬 USD | 25萬 USD | — |
| 利息支出 | — | — | — | — | 15.7萬 USD |
| 折舊和攤銷 | 47.6萬 USD | 28萬 USD | 23.2萬 USD | 18.8萬 USD | 16.1萬 USD |
| 營業利益 | −4911.2萬 USD | −3350.3萬 USD | −2114.3萬 USD | −1871.3萬 USD | −1471.6萬 USD |
| 淨利 | −4878.6萬 USD | −3200.5萬 USD | −1991.6萬 USD | −1849.1萬 USD | −1491.8萬 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$3.50
上漲空間 571.79%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2021年4月27日 | 1:15 | — | — |
股票分割 | 2019年4月1日 | 1:50 | — | — |
股票分割 | 2018年2月8日 | 1:35 | — | — |
股票分割 | 2016年10月10日 | 1:25 | — | — |
股票分割 | 2015年10月1日 | 1:10 | — | — |
股票分割 | 2012年12月21日 | 1:4 | — | — |
已生效 2021年4月27日
1:15
已生效 2019年4月1日
1:50
已生效 2018年2月8日
1:35
已生效 2016年10月10日
1:25
已生效 2015年10月1日
1:10
已生效 2012年12月21日
1:4
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
